News / Health

US Approves Drug-Resistant Tuberculosis Treatment

X-rays from a tuberculosis patient at A. G. Holley Hospital in Lantana, Florida, Dec. 2009 (file photo).
X-rays from a tuberculosis patient at A. G. Holley Hospital in Lantana, Florida, Dec. 2009 (file photo).
VOA News
The U.S. Food and Drug Administration has approved a new medication for treating multi-drug resistant tuberculosis (MDR-TB).
 
Sirturo, known chemically as bedaquiline, is the first new anti-TB therapy approved in more than 40 years. It is also the first designed as part of a combination therapy to treat adults infected with drug-resistant pulmonary TB, when other treatments are unavailable. The new drug works by blocking an enzyme the disease pathogen needs to spread throughout the body.
 
Developed by Janssen Therapeutics, a division of U.S. drugmaker Johnson & Johnson, Sirturo was approved under the FDA’s accelerated review program that allows promising drugs to be brought to market more quickly.
 
The federal agency cautions that the medication carries risks of potentially deadly heart problems, and advises doctors to prescribe and administer Sirturo carefully. A consumer health group, Public Citizen, criticized the FDA’s accelerated review of bedaquiline, saying its apparent toxicity “means an increased level of scrutiny should be required for its approval.”
 
But Dr. Mel Spigelman, president and CEO of the non-profit Global Alliance for TB Drug Development, calls the FDA's approval of Sirturo "the beginning of a new era" in TB treatment. He predicts more powerful therapies will soon emerge to replace the few drugs that have been used to treat TB for the past half-century.
 
Tuberculosis is one of the world's leading killers. An estimated two-billion people carry the bacterial respiratory infection; more than nine-million people, many living in poverty, have an active form of the disease, which can be spread easily from person to person through the air, by coughing, and by poor sanitary conditions.
 
Of the nine-million active cases of TB, about half a million are caused by multi-drug resistant tuberculosis, which manifests when the disease pathogen Mycobacterium tuberculosis becomes resistant to isonazid and rifampin, the two drugs most widely used to treat TB.
 
There were fewer than 100 cases of MDR-TB in the United States last year, but this hard-to-treat and deadlier form of TB poses a growing public health threat throughout much of the developing world, especially in regions of Africa, China, South Asia and Eastern Europe.
 
The new drug is approved for use only in the United States.

You May Like

Video On the Scene: In Gaza, Darkness Brings Dread and Death

Palestinians fear nighttime raids, many feel abandoned by outside world, VOA's Scott Bobb reports More

African Small Farmers Could Be Key to Ending Food Insecurity

Experts say providing access to microloans, crop insurance, better storage facilities, irrigation, road systems and market information could enable greater production More

University of Michigan Wins Solar Car Race

Squad guided its student-designed solar-powered vehicle to fifth consecutive time victory in eight-day bi-annual American Solar Challenge More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Vietnamese Staging Chinese Product Boycott After Oil Rig Spati
X
Reasey Poch
July 28, 2014 7:18 PM
China recently pulled an oil rig from an area of the disputed South China Sea that Vietnam also claims. Despite the action, the incident has had a lingering effect on consumers in Vietnam. VOA's Reasey Poch reports from Hanoi on an effort to boycott Chinese products.
Video

Video Vietnamese Staging Chinese Product Boycott After Oil Rig Spat

China recently pulled an oil rig from an area of the disputed South China Sea that Vietnam also claims. Despite the action, the incident has had a lingering effect on consumers in Vietnam. VOA's Reasey Poch reports from Hanoi on an effort to boycott Chinese products.
Video

Video ESA Spacecraft to Land on a Comet

After a long flight through deep space, a European Space Agency probe is finally approaching its target -- a comet millions of kilometers away from earth. Scientists say the mission may lead to some startling discoveries about the origins of the water on earth. VOA’s George Putic has more.
Video

Video Young Africans Arrive in US for Leadership Program

President Barack Obama's Young African Leadership Initiative has brought hundreds of young Africans to the United States for a six-week program aimed at building their knowledge and skills in fields such as public administration and business. Out of the 50,000 young Africans who applied for the program, just one percent was accepted. VOA's Laurel Bowman caught up with some of those who made the cut and has this report.
Video

Video In Honduras, Amnesty Rumors Fuel US Migration Surges

False rumors in Central America are fueling the current surge of undocumented young people being apprehended at the U.S. border. The inaccurate claims suggest the U.S. will give amnesty to young migrants from the region. As VOA's Brian Padden reports from Honduras, these rumors trace back to President Obama's 2012 executive order to halt deportations for some young undocumented immigrants already living in the United States.
Video

Video Students in Business for Themselves

They're only high school students, but they are making accessories for shoes, fabricating backpacks and doing product photography - all through their own businesses. It's the result of a partnership between a non-profit organization that teaches entrepreneurship and their schools. VOA's Mike O'Sullivan and Deyane Moses met the budding entrepreneurs near Los Angeles.
Video

Video Astronauts Train in Underwater Lab

In the world’s only underwater laboratory, four U.S. astronauts train for a planned visit to an asteroid. The lab - called Aquarius- is located five kilometers off Key Largo, in southern Florida. Living in close quarters and making excursions only into the surrounding ocean, they try to simulate the daily routine of a crew that will someday travel to collect samples of a rock orbiting far away from earth. VOA’s George Putic has more.

AppleAndroid